Recent advances in nuclear cardiology

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

Recent advances in nuclear cardiology. / Gutte, H.; Petersen, C. Leth; Kjaer, A.; Hesse, B.

In: Panminerva Medica, Vol. 50, No. 2, 2008, p. 105-118.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Gutte, H, Petersen, CL, Kjaer, A & Hesse, B 2008, 'Recent advances in nuclear cardiology', Panminerva Medica, vol. 50, no. 2, pp. 105-118.

APA

Gutte, H., Petersen, C. L., Kjaer, A., & Hesse, B. (2008). Recent advances in nuclear cardiology. Panminerva Medica, 50(2), 105-118.

Vancouver

Gutte H, Petersen CL, Kjaer A, Hesse B. Recent advances in nuclear cardiology. Panminerva Medica. 2008;50(2):105-118.

Author

Gutte, H. ; Petersen, C. Leth ; Kjaer, A. ; Hesse, B. / Recent advances in nuclear cardiology. In: Panminerva Medica. 2008 ; Vol. 50, No. 2. pp. 105-118.

Bibtex

@article{eca82bc0058f11deb05e000ea68e967b,
title = "Recent advances in nuclear cardiology",
abstract = "Nuclear cardiology is an essential part of functional, non-invasive, cardiac imaging. Significant advances have been made in nuclear cardiology since planar (201)thallium ((201)TI) scintigraphy was introduced for the evaluation of left ventricular (LV) perfusion nearly 40 years ago. The use of nuclear cardiology has been steadily increasing over the last 20 years with important steps being the introduction of (99m)technetium- ((99m)Tc)-labelled perfusion radiotracers, the change from only planar to now much more single photon emission computed tomography (SPECT) and positron emission tomography (PET), electrocardiogram gating of nuclear perfusion imaging, and finally introducing nuclear hybrid imaging using either SPECT or PET together with either computed tomography or magnetic resonance imaging. The indications have extended from nearly only coronary artery diseases to several non-coronary cardiac diseases. The advances in nuclear cardiology are discussed under the four headlines of: 1) myocardial perfusion, 2) cardiac performance including LV and right ventricular (RV) function, 3) myocardial metabolism, and 4) experimental nuclear cardiology Udgivelsesdato: 2008/6",
author = "H. Gutte and Petersen, {C. Leth} and A. Kjaer and B. Hesse",
year = "2008",
language = "English",
volume = "50",
pages = "105--118",
journal = "Panminerva Medica",
issn = "0031-0808",
publisher = "EdizioniMinerva Medica",
number = "2",

}

RIS

TY - JOUR

T1 - Recent advances in nuclear cardiology

AU - Gutte, H.

AU - Petersen, C. Leth

AU - Kjaer, A.

AU - Hesse, B.

PY - 2008

Y1 - 2008

N2 - Nuclear cardiology is an essential part of functional, non-invasive, cardiac imaging. Significant advances have been made in nuclear cardiology since planar (201)thallium ((201)TI) scintigraphy was introduced for the evaluation of left ventricular (LV) perfusion nearly 40 years ago. The use of nuclear cardiology has been steadily increasing over the last 20 years with important steps being the introduction of (99m)technetium- ((99m)Tc)-labelled perfusion radiotracers, the change from only planar to now much more single photon emission computed tomography (SPECT) and positron emission tomography (PET), electrocardiogram gating of nuclear perfusion imaging, and finally introducing nuclear hybrid imaging using either SPECT or PET together with either computed tomography or magnetic resonance imaging. The indications have extended from nearly only coronary artery diseases to several non-coronary cardiac diseases. The advances in nuclear cardiology are discussed under the four headlines of: 1) myocardial perfusion, 2) cardiac performance including LV and right ventricular (RV) function, 3) myocardial metabolism, and 4) experimental nuclear cardiology Udgivelsesdato: 2008/6

AB - Nuclear cardiology is an essential part of functional, non-invasive, cardiac imaging. Significant advances have been made in nuclear cardiology since planar (201)thallium ((201)TI) scintigraphy was introduced for the evaluation of left ventricular (LV) perfusion nearly 40 years ago. The use of nuclear cardiology has been steadily increasing over the last 20 years with important steps being the introduction of (99m)technetium- ((99m)Tc)-labelled perfusion radiotracers, the change from only planar to now much more single photon emission computed tomography (SPECT) and positron emission tomography (PET), electrocardiogram gating of nuclear perfusion imaging, and finally introducing nuclear hybrid imaging using either SPECT or PET together with either computed tomography or magnetic resonance imaging. The indications have extended from nearly only coronary artery diseases to several non-coronary cardiac diseases. The advances in nuclear cardiology are discussed under the four headlines of: 1) myocardial perfusion, 2) cardiac performance including LV and right ventricular (RV) function, 3) myocardial metabolism, and 4) experimental nuclear cardiology Udgivelsesdato: 2008/6

M3 - Journal article

VL - 50

SP - 105

EP - 118

JO - Panminerva Medica

JF - Panminerva Medica

SN - 0031-0808

IS - 2

ER -

ID: 10904793